期刊文献+

大鼠骨髓间充质干细胞转染人TH基因的实验研究 被引量:1

Research on rat bone mesenchymal stem cells transfected with human tyrosine hydroxylase gene in vitro
原文传递
导出
摘要 目的 评价酪氨酸羟化酶(tyrosine hydroxylase,TH)基因修饰骨髓间充质干细胞(mesenchymalstem cells,MSCs)后TH的表达情况及转染TH基因对MSCs的影响。方法 构建含人TH基因的pCMV/hTH质粒,用脂质体转染原代培养的大鼠MSCs;Western blot及免疫细胞化学染色鉴定TH基因的表达及MSCs的分化情况;MTT比色法测定转染后的MSCs细胞活性,并与未转染的MSCs进行细胞活性比较。结果 构建的pCMV/hTH质粒经ECoRI酶切后产生1.9 kb和5.3 kb的片段,与回收的目的基因及载体基因片段大小相符;转基因后的MSCs Western blot及免疫细胞化学染色显示TH染色阳性;转染后MSCs未见有NeuN,GFAP的表达;MTT比色法测定细胞活性,未转染与转染者差异无显著性。结论 构建的TH基因能在体外培养的鼠MSCs中较好的表达,转染不会诱导MSCs向神经样细胞分化,对MSCs细胞活性无明显影响。 Objective To evaluate the expression efficiency of TH (tyrosine hydroxylase) gene after it being transduced into rat mesenchymal stem cells (rMSCs) and the influence of the transfection. Methods Plasmid containing human TH gene was constructed by using the cytomegalovirus (CMV) promoter to drive its expression, and then transfect the primary cultured rMSCs by Lipofect Amine; We verify the expression and the differentiation using Western blot and immunocytochemical staining, and compare the transfected MSCs activity with the untransfected MSCs by MTT colorimetric metrod. Results The pCMV/hTH can produce 1.9 kb and 5.3 kb fragment after cutting by restriction enzyme ECoRI which was in accordance with anticipated result; Western blot and immunhisto-chemical staining of post-transgeneic rMSC transfeced showed TH positive and NeuN, GFAP Negative; MTT colorimetric metrod showed no significant difference between transfected MSCs and untransfected MSCs. Conclusions Rat mesenchymal stem cells constructed by gene transfection can express human TH gene in vitro. The TH gene-cannot induce MSCs' differentiation and has no significant influence on the cells's activity.
出处 《卒中与神经疾病》 2004年第2期82-85,106,共5页 Stroke and Nervous Diseases
关键词 大鼠 骨髓间充质干细胞 基因转染 人TH基因 转基因动物 Mesenchymal stem cells Bone marrow Gene transfetion Tyrosine hydroxylase
  • 相关文献

参考文献4

二级参考文献15

  • 1Cao L,Gene Therapy,2000年,7卷,445页
  • 2Xu D H,生物化学与生物物理学报,2000年,32卷,4期,347页
  • 3Jiang Q,生物化学与生物物理学报,1999年,31卷,2期,150页
  • 4Chen L S,J Cell Biochem,1991年,45卷,252页
  • 5Im GI;Kim DY;Shin JH.Repair of cartilage defect in the rabbit with cultured mesenchymal stem cells from bone marrow,2001.
  • 6Pittenger MF;Mackay AM;Beck SC.Multilineage potential of adult human mesenchymal stem cells[J],1999(5411).
  • 7Prockop DJ.Marrow stromal cells as stem cells for nonhematopoietic tissues[J],1997(5309).
  • 8Majumdar MK;Thiede MA;Mosca JD.Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells(MSCs) and stromal cells[J],1998.
  • 9Deans RJ;Moseley AB.Mesenchymal stem cells: Biology and potential clinical uses[J],2000.
  • 10Koc ON;Lazarus HM.Mesenchymal stem cells: heading into the clinic[J],2001(3).

共引文献35

同被引文献17

  • 1杨华静,徐光锦,褚倩,张苏明.对比研究经颈动脉和立体定位注射骨髓间充质干细胞治疗缺血性脑卒中[J].卒中与神经疾病,2005,12(2):77-79. 被引量:18
  • 2Tondreau T, Lagneaux L, Dejeneffe M, et al. Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation. Differentiation, 2004,72 ( 7 ) : 319-326.
  • 3Wislet Gendebien S,Wautier F, Leprince P, et al. Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin. Brain Res Bull.2005,68(1 2) :95-102.
  • 4Zhao LR,Duan WM,Reyes M, et al. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brains of rats. Exp Neurol, 2002,174 ( 1 ) : 33-20.
  • 5Li Y,Chen J,Wang L,et al. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurol, 2001, 56(12) ; 1666 1672.
  • 6Zhu W, Chen, J,Cong X, et al. Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells, 2006,24 (2) :416-425.
  • 7Pit tenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999,284 (2) : 143-347.
  • 8Colter DC,Class R, DiGirolamo CM, et al. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA,2000,97(7) :3213-3218.
  • 9Kazuhiko K, Kimianori N, Takashi T, et al. BDNF gene-modified mesenchymal stem cells promote functinal recovery and reduced infarct size in the rat middle cerebral artery occlusion model. Mo- lecular Therapy, 2004, 9 (2) : 189-197.
  • 10Yin XM,Oltvai ZN,Korsmery SJ. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature,1994,369(6478) :321-323.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部